181 related articles for article (PubMed ID: 17880582)
61. High expression of Ki-67 and cyclin D1 in invasive extramammary Paget's disease.
Aoyagi S; Akiyama M; Shimizu H
J Dermatol Sci; 2008 Jun; 50(3):177-84. PubMed ID: 18248961
[TBL] [Abstract][Full Text] [Related]
62. Impact of ultraviolet radiation on the expression of marker proteins of gap and adhesion junctions in human epidermis.
Gambichler T; Rotterdam S; Tigges C; Altmeyer P; Bechara FG
Photodermatol Photoimmunol Photomed; 2008 Dec; 24(6):318-21. PubMed ID: 19000190
[TBL] [Abstract][Full Text] [Related]
63. Regeneration of human epidermis on acellular dermis is impeded by small-molecule inhibitors of EGF receptor tyrosine kinase.
Forsberg S; Ostman A; Rollman O
Arch Dermatol Res; 2008 Oct; 300(9):505-16. PubMed ID: 18446355
[TBL] [Abstract][Full Text] [Related]
64. Epidermal-type FABP is a predictive marker of clinical response to systemic treatment and ultraviolet therapy in psoriatic skin lesions.
Miyake T; Ogawa E; Mikoshiba A; Kobayashi A; Hosoe H; Kashiwabara S; Uhara H; Owada Y; Okuyama R
J Dermatol Sci; 2012 Dec; 68(3):199-202. PubMed ID: 23039948
[No Abstract] [Full Text] [Related]
65. Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells.
Krueger JG; Wolfe JT; Nabeya RT; Vallat VP; Gilleaudeau P; Heftler NS; Austin LM; Gottlieb AB
J Exp Med; 1995 Dec; 182(6):2057-68. PubMed ID: 7500051
[TBL] [Abstract][Full Text] [Related]
66. Lack of effect of oral selenite on p53 associated gene expression during TL01 therapy of psoriasis patients.
DeSilva B; Beckett GJ; McLean S; Arthur JR; Hunter JA; Norval M; McKenzie RC
Photodermatol Photoimmunol Photomed; 2007; 23(2-3):98-100. PubMed ID: 17523932
[TBL] [Abstract][Full Text] [Related]
67. CD26/dipeptidyl-peptidase IV in psoriatic skin: upregulation and topographical changes.
van Lingen RG; van de Kerkhof PC; Seyger MM; de Jong EM; van Rens DW; Poll MK; Zeeuwen PL; van Erp PE
Br J Dermatol; 2008 Jun; 158(6):1264-72. PubMed ID: 18384439
[TBL] [Abstract][Full Text] [Related]
68. Focused UV-B narrowband microphototherapy (Biopsorin). A new treatment for plaque psoriasis.
Lotti T; Tripo L; Grazzini M; Krysenka A; Buggiani G; De Giorgi V
Dermatol Ther; 2009; 22(4):383-5. PubMed ID: 19580582
[TBL] [Abstract][Full Text] [Related]
69. Digital image analysis for the evaluation of the inflammatory infiltrate in psoriasis.
Goedkoop AY; de Rie MA; Teunissen MB; Picavet DI; van der Hall PO; Bos JD; Tak PP; Kraan MC
Arch Dermatol Res; 2005 Aug; 297(2):51-9. PubMed ID: 16012877
[TBL] [Abstract][Full Text] [Related]
70. Fumaric acid esters (FAEs) suppress CD 15- and ODP 4-positive cells in psoriasis.
Bacharach-Buhles M; Pawlak FM; Matthes U; Joshi RK; Altmeyer P
Acta Derm Venereol Suppl (Stockh); 1994; 186():79-82. PubMed ID: 7915483
[TBL] [Abstract][Full Text] [Related]
71. Single administration of lesion-limited high-dose (TURBO) ultraviolet B using the excimer laser: clinical clearing in association with apoptosis of epidermal and dermal T cell subsets in psoriasis.
Kagen M; Cao LY; Oyetakin-White P; Tacastacas JD; Yan C; McCormick TS; Cooper KD
Photodermatol Photoimmunol Photomed; 2012 Dec; 28(6):293-8. PubMed ID: 23126290
[TBL] [Abstract][Full Text] [Related]
72. Correlation of histological findings of single session Er:YAG skin fractional resurfacing with various passes and energies and the possible clinical implications.
Trelles MA; Vélez M; Mordon S
Lasers Surg Med; 2008 Mar; 40(3):171-7. PubMed ID: 18366083
[TBL] [Abstract][Full Text] [Related]
73. Nd: YAG laser (1,064 nm) fails to improve localized plaque type psoriasis: a clinical and immunohistochemical pilot study.
van Lingen RG; de Jong EM; van Erp PE; van Meeteren WS; van De Kerkhof PC; Seyger MM
Eur J Dermatol; 2008; 18(6):671-6. PubMed ID: 18955206
[TBL] [Abstract][Full Text] [Related]
74. 312-nanometer ultraviolet B light (narrow-band UVB) induces apoptosis of T cells within psoriatic lesions.
Ozawa M; Ferenczi K; Kikuchi T; Cardinale I; Austin LM; Coven TR; Burack LH; Krueger JG
J Exp Med; 1999 Feb; 189(4):711-8. PubMed ID: 9989986
[TBL] [Abstract][Full Text] [Related]
75. Immunohistochemical study before and after narrow band (311 nm) UVB treatment in vitiligo.
De Francesco V; Stinco G; Laspina S; Parlangeli ME; Mariuzzi L; Patrone P
Eur J Dermatol; 2008; 18(3):292-6. PubMed ID: 18474458
[TBL] [Abstract][Full Text] [Related]
76. Immunohistochemical study of osteopontin, Ki-67, and CD34 of psoriasis in Mansoura, Egypt.
Amin MM; Azim ZA
Indian J Pathol Microbiol; 2012; 55(1):56-60. PubMed ID: 22499302
[TBL] [Abstract][Full Text] [Related]
77. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
Bhatnagar A; Kanwar AJ; Parsad D; De D
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
[TBL] [Abstract][Full Text] [Related]
78. Very late antigen-1 in psoriasis: an immunohistochemical study.
Baum S; Barzilai A; Huszar M; Greenberger S; Trau H; Bank I
J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):283-9. PubMed ID: 18269595
[TBL] [Abstract][Full Text] [Related]
79. Caspase 9 is decreased in psoriatic epidermis.
Oztaş P; Lortlar N; Oztaş MO; Omeroglu S; Gürer MA; Alli N
Acta Histochem; 2006; 108(6):497-9. PubMed ID: 17034836
[TBL] [Abstract][Full Text] [Related]
80. [Analysis of lymphocyte populations in psoriatic plaques following inhibition of tumor necrosis factor alpha with etanercept].
Mahiques L; Pitarch G; Sánchez-Carazo JL; Pérez-Ferriols A; Soriano CJ; Alegre V
Actas Dermosifiliogr; 2007 Oct; 98(8):539-44. PubMed ID: 17919428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
